New drug NS-079 tested in healthy people for first time
NCT ID NCT07669571
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase trial will test the safety and how the body processes a new drug called NS-079 in 78 healthy adults aged 18 to 55. Participants will receive either NS-079 or a placebo, and some will also take paroxetine to check for drug interactions. The study aims to gather basic safety information, not to treat any disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
NS-079
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT PARTICIPANTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chengdu Xinhua Hospital
Chengdu, Sichuan, 610000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••